LON:SPEC INSPECS Group (SPEC) Share Price, News & Analysis → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free SPEC Stock Alerts GBX 56 0.00 (0.00%) (As of 04/30/2024 ET) Add Compare Share Share Today's Range 55▼ 57.2550-Day Range 47▼ 6152-Week Range 46▼ 139.94Volume237,194 shsAverage Volume394,560 shsMarket Capitalization£56.94 millionP/E RatioN/ADividend Yield1.79%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisChartCompetitorsDividendHeadlinesInsider Trades Get INSPECS Group alerts: Email Address Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details About INSPECS Group Stock (LON:SPEC)INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products worldwide. It distributes frames and optical products. The company offers its eyewear under the Viktor & Rolf, Valerie, Lyle & Scott, Barbour, Liberty, Henri Lloyd, O'Neill, Caterpillar, BOTANIQ, and other brand names. The company sells its products through various retail outlets directly to retailers, distributors, and brand owners. INSPECS Group plc was founded in 1988 and is based in Bath, the United Kingdom.Read More SPEC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SPEC Stock News HeadlinesApril 26, 2024 | msn.comEyewear firm named fastest-growing company in South WestApril 22, 2024 | lse.co.ukInspecs Group Share ChatApril 30, 2024 | The Bull Report (Ad)Healthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.April 18, 2024 | msn.comFTSE 100 Live 17 April: Shares higher after yesterday's big fall, Royal Mail owner soars after bidApril 18, 2024 | finance.yahoo.comHere's What's Concerning About INSPECS Group's (LON:SPEC) Returns On CapitalApril 17, 2024 | msn.comFTSE 100 Live 17 April: UK Inflation at 3.2%, shares rally after big fall yesterday, shock Royal Mail bidApril 17, 2024 | lse.co.ukInspecs hails "encouraging" recent trading after tepid start to 2024March 27, 2024 | uk.investing.comInspecs Group PLC (SPECI)April 30, 2024 | Gold Gate Capital (Ad)Urgent Alert: Is the U.S. Implementing a Digital Dollar?Our exclusive guide, "Exploring the Future of the U.S. Dollar in a Digital World," is your essential resource in navigating this uncertain terrain. Inside, you'll find expert insights, strategies, and actionable steps to shield your wealth from the impending digital dollar storm.March 16, 2024 | msn.comClearwater accountant arrested after stealing $700K from boss, deputies sayMarch 16, 2024 | finance.yahoo.comClearwater woman stole $700,000 from Palm Harbor eyewear company, deputies sayMarch 2, 2024 | morningstar.comInspecs Group PLC Ordinary Shares SPECFebruary 27, 2024 | morningstar.comInspecs Group PLC Ordinary SharesJanuary 29, 2024 | morningstar.comFTSE 100 Starts Week Flat, With Oil-Stock Gains Offset by Falls ElsewhereJanuary 29, 2024 | lse.co.ukAIM WINNERS & LOSERS: Surgical Innovations shares jump as revenue upJanuary 29, 2024 | lse.co.ukInspecs eyes profit rise short of market expectations on weak DecemberJanuary 29, 2024 | marketwatch.comInspecs Revenue Misses Company Expectations; Remains Positive for New YearJanuary 18, 2024 | finance.yahoo.comCalculating The Intrinsic Value Of INSPECS Group plc (LON:SPEC)October 30, 2023 | msn.comFTSE 100 Live: HSBC profits grow, mortgage approvals fall, blue-chips close higherOctober 30, 2023 | msn.comDesigner eyewear firm Inspecs sees revenues soar to almost £160 millionOctober 30, 2023 | lse.co.ukInspecs Group shares rise on "solid" trading so far in 2023October 30, 2023 | marketwatch.comInspecs Group's Revenue Rose in First Nine Months of the YearOctober 6, 2023 | finance.yahoo.comINSPECS Group Insiders Placed Bullish Bets Worth UK£456kSeptember 9, 2023 | finance.yahoo.comWhen Should You Buy INSPECS Group plc (LON:SPEC)?September 9, 2023 | finance.yahoo.comINSPECS Group First Half 2023 Earnings: EPS: UK£0.02 (vs UK£0.022 loss in 1H 2022)September 7, 2023 | msn.comDesigner eyewear firm Inspecs sees revenue increase by 6 per centSeptember 7, 2023 | msn.comDesigner eyewear firm Inspecs sees annual revenue increase by 6 per centSee More Headlines Receive SPEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for INSPECS Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolLON:SPEC CUSIPN/A CIKN/A Webinspecs.com Phone44 1125 717 000FaxN/AEmployees1,732Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.02) Trailing P/E RatioN/A Forward P/E Ratio11.98 P/E GrowthN/ANet Income£-1,190,000.00 Net Margins-0.59% Pretax MarginN/A Return on Equity-1.10% Return on Assets-0.03% Debt Debt-to-Equity Ratio62.87 Current Ratio1.54 Quick Ratio0.89 Sales & Book Value Annual Sales£202 million Price / Sales0.29 Cash FlowGBX 35.01 per share Price / Cash Flow1.63 Book ValueGBX 104 per share Price / Book0.55Miscellaneous Outstanding Shares101,670,000Free FloatN/AMarket Cap£57.95 million OptionableNot Optionable Beta2.26 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Robin B.C. Totterman (Age 64)Founder & Executive Chairman Comp: $251.49kMr. Richard D. Peck (Age 60)Group CEO & Non-Executive Director Comp: $98.94kMr. Christopher D. Kay (Age 61)Group CFO & Director Comp: $238.27kMartin BatesSales DirectorMr. Steve TulbaManaging Director of Inspecs DivisionKey CompetitorsBATM Advanced CommunicationsLON:BVCAkers BiosciencesLON:AKRPoolbeg PharmaLON:POLBe-therapeuticsLON:ETXVenture Life GroupLON:VLGView All Competitors SPEC Stock Analysis - Frequently Asked Questions How have SPEC shares performed in 2024? INSPECS Group's stock was trading at GBX 84 at the beginning of 2024. Since then, SPEC shares have decreased by 33.3% and is now trading at GBX 56. View the best growth stocks for 2024 here. Is INSPECS Group a good dividend stock? INSPECS Group (LON:SPEC) pays an annual dividend of GBX 1 per share and currently has a dividend yield of 2.00%. Read our dividend analysis for SPEC. How do I buy shares of INSPECS Group? Shares of SPEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:SPEC) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersThe Gold Grab of the CenturyColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsIs Tesla going out of business?DTIREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingElon Musk Secret Crypto Plot ExposedCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INSPECS Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
